Stay updated on PD-1 Inhibitor Combo with Gem/Cispl Clinical Trial
Sign up to get notified when there's something new on the PD-1 Inhibitor Combo with Gem/Cispl Clinical Trial page.

Latest updates to the PD-1 Inhibitor Combo with Gem/Cispl Clinical Trial page
- Check3 days agoChange DetectedThe ClinicalTrials.gov site revision identifier changes from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check10 days agoChange DetectedThe page now presents the study record for a phase I/II trial of a PD-1 inhibitor with gemcitabine and cisplatin for advanced biliary tract cancer, including its eligibility criteria, treatment plan, outcomes, and contact details.SummaryDifference51%

- Check17 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check31 days agoChange DetectedA banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence.” The site revision advances from v3.7.1 to v3.7.2, while the study page continues to show a 403 error.SummaryDifference1%

- Check45 days agoChange DetectedThe site revision number in the footer changed from v3.7.0 to v3.7.1, while the page continues to display a 403 error.SummaryDifference0.2%

- Check59 days agoChange DetectedThe study page now displays a 403 Forbidden error, blocking access to the study record and its details. This indicates an access or server issue rather than a content update to the trial information.SummaryDifference18%

Stay in the know with updates to PD-1 Inhibitor Combo with Gem/Cispl Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1 Inhibitor Combo with Gem/Cispl Clinical Trial page.